GUIDANCE DOCUMENT
Validation and Verification of Analytical Testing Methods Used for Tobacco Products January 2025
- Docket Number:
- FDA-2021-D-0756
- Issued by:
-
Guidance Issuing OfficeCenter for Tobacco Products
This is a final guidance providing tobacco manufacturers with information and recommendations to aid application submissions. The guidance explains how manufacturers can provide FDA with validated and verified data for the analytical procedures and test methods used in application submissions to the agency – including premarket tobacco product applications, substantial equivalence reports, and modified risk tobacco product applications.
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2021-D-0756.
Questions?
- Contact CTP
- Center for Tobacco Products
Food and Drug Administration
Document Control Center
10903 New Hampshire Avenue
Building 71, Room G335
Silver Spring, MD 20993-0002
- AskCTP@fda.hhs.gov
- (9 a.m. - 4 p.m. Eastern) 1-877-CTP-1373 (1-877-287-1373)
- Twitter: https://twitter.com/FDATobacco
- FDA Tobacco Education Resource Library: https://digitalmedia.hhs.gov/tobacco